Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1993-10-07
1996-12-03
Fleisher, Mindy
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
4353201, 530358, 536 234, C12Q 168, C12N 1562, C12N 1585, A61K 3816
Patent
active
055807216
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
This invention relates to methods for identifying anti-cancer therapeutics.
The induction of many types of cancer is thought to be ultimately caused by the products of activated cellular oncogenes (Bishop, J. M., Science 235:305-310, 1987; Barbacid, M., Ann. Rev. Biochem. 56:779-827, 1987; Cole, M. D., Ann. Rev. Genet. 20:361-384, 1986; and Weinberg, R. A., Science 230:770-776, 1985). Such oncogenes express oncoproteins that reside in the cell, often localized to specific cellular compartments such as the nucleus, cytoplasm or cell membrane.
In particular examples, the vital and cellular fos and myc oncogenes encode the Fos and Myc proteins, respectively. Expression of a large amount of either Fos or Myc in a variety of cell types allows the cells to grow indefinitely in cell culture (reviewed in Bishop, J. M. Cell 42:23-38, 1985; and Weinberg, R. A., Science 230:770-776, 1985). Overexpression of either Fos or Myc in normal rat fibroblasts, together with expression of an activated ras oncogene product, transforms the fibroblasts and endows them with the ability to form tumors in living animals (Land, H. et al., Nature 304:596-601, 1983; Ruley, H. E., Nature 304:602-606, 1983).
Fos and Myc are examples of oncoproteins that are phosphorylated, localized to the cell nucleus, and possess an ability to alter transcription (Donner, P. et al., Nature 296:262-266, 1982; Watt, R. A. et al., Mol. Cell Biol. 5:448-456, 1985; Renz M. et al., Nucl. Acids Res. 5:277-292, 1987). Recent studies suggest that oncoproteins such as Fos and Myc alter gene expression and immortalize cells by regulating the promoter activity of specific target genes and thus activating or repressing transcription of those target genes (see, for example, Varmus, H. E. Science 238:1337-1339, 1987; Kingston, R. E. et al., Cell 41:3-5, 1985; Bishop, J. M., Cell 42:23-38, 1985; Weinberg, R. A., Science 230:770-776, 1985).
Other oncoproteins are also thought to be involved in gene regulation. For example, the nuclear-localized oncogene product of v-jun (viral jun) binds to specific sites on DNA (Struhl, K., Cell 50:841-846, 1987) and is homologous to the c-jun (cellular jun) product, which also binds specific sites on DNA. The jun gene product appears to be identical to the previously characterized transcription factor AP-1 (Bohmann, D. et al. Science 238:1386-1392, 1987).
It is desirable to identify compounds that inhibit oncoprotein activity. By inhibiting oncoprotein activity, inhibition and/or control of oncoprotein-induced cell growth may be achieved. Especially, it is desirable to identify inhibitors of oncoproteins that do not alter the activity of the normal cellular equivalents of the oncoproteins. Administration of such inhibitors would provide therapeutic benefits in the treatment of diseases in which expression and activity of the oncoprotein is a factor in promoting cell growth or in maintaining the cell in a transformed state.
However, to date, very few oncoprotein inhibitors have been identified. The identification of such inhibitors has suffered for lack of a simple, inexpensive and reliable screening assay that could rapidly identify potential inhibitors and active derivatives thereof. The present invention provides such an assay. Using the instant assay, inhibitors of oncoprotein activity can be identified and, if desired, those inhibitors further screened to eliminate ones which generally inhibit normal cellular transcription or which inhibit activity of the normal cellular oncoprotein homologs.
SUMMARY OF THE INVENTION
Recognizing the importance that inhibitors of oncoproteins would play in the therapeutic treatment of many forms of cancer, and cognizant of the lack of a simple assay system in which such inhibitors might be identified, the inventors have investigated the use of chimeric oncogene constructs in in vivo assays in eukaryotic hosts as a model system in which to identify agents that alter oncogene expression. These. efforts have culminated in the development of a simple, inexpensive assay
REFERENCES:
patent: 4833080 (1989-05-01), Brent
patent: 4980281 (1990-12-01), Housey
Ammerer; "Expression of Genes in Yeast Using the ADCI Promoter;" Methods in Enzymology, 101:192-211, 1983.
Astell et al.; "The Sequence of the DNAs Coding for the Mating-Type Loci of Saccharomyces Cerevisiae;" Cell 27:15-23, 1981.
West et al.; "Saccharomyces cerevisiae GAL1-GAL10 Divergent Promoter Region: Location and Function of the Upstream Activating Sequence UAS.sub.G ;" Molecular and Cellular Biology, 4:2467-2478, 1984.
Godowski et al., "Signal Transduction and Transcriptional Regulation by Glucocorticoid Receptor-LexA Fusion Proteins;" Science 241:812-816, 1988.
Busch et al. (1990), Clin. Res. 38(2), 411A, Abstract Only.
Penn et al (1990) Mol. Cell Biol. 10(9), 4961-4966.
Levine et al., Cell, 59:405-408, 1989.
Struhl, Annu. Rev. Biochem, 58:1051-1077, 1989.
Hansen et al., Cell, 53:172-173, 1988.
Struhl, Nature, 332:649-650, Apr. 14, 1988.
Lech et al., Cell, 52:179-184, 1988.
Bishop, Science, 235:305-311, 1987.
Brent et al., Cell, 43:729-736, 1985.
Giniger et al., Cell, 40:767-774, 1985.
Brent et al., Nature, 312:612-615, 1984.
Reddy et al., Proc. Natl. Acad. Sci. USA, 80:2500-2504, 1983.
Van Beveren et al., Cell, 32:1241-1255, 1983.
Anderson Catherine
Brent Roger
Golemis Erica
Lech Karen F.
Carter Philip W.
Fleisher Mindy
The General Hospital Corporation
LandOfFree
Assays for inhibitors of myc oncoprotein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assays for inhibitors of myc oncoprotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assays for inhibitors of myc oncoprotein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-784431